Bangor Savings Bank decreased its stake in UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 5.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,060 shares of the healthcare conglomerate’s stock after selling 64 shares during the period. Bangor Savings Bank’s holdings in UnitedHealth Group were worth $ 541,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Outfitter Financial LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $ 25,000. Blue Bell Private Wealth Management LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $ 29,000. Advocacy Wealth Management Services LLC lifted its stake in UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $ 30,000 after purchasing an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. lifted its stake in UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $ 31,000 after purchasing an additional 30 shares during the last quarter. Finally, Tortoise Investment Management LLC lifted its stake in UnitedHealth Group by 54.8% in the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $ 33,000 after purchasing an additional 23 shares during the last quarter. Institutional investors own 87.48% of the company stock.
NYSE UNH opened at $ 495.64 on Friday. The firm’s fifty day moving average price is $ 495.07 and its two-hundred day moving average price is $ 491.35. The stock has a market cap of $ 465.00 billion, a PE ratio of 27.13, a PEG ratio of 1.52 and a beta of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $ 383.12 and a fifty-two week high of $ 553.29. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78.
UnitedHealth Group (NYSE: UNH – Get Rating) last issued its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 EPS for the quarter, topping analysts’ consensus estimates of $ 5.40 by $ 0.09. The company had revenue of $ 80.15 billion for the quarter, compared to analyst estimates of $ 78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. UnitedHealth Group’s revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $ 5.31 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be issued a $ 1.65 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $ 1.45. The ex-dividend date is Thursday, June 16th. This represents a $ 6.60 annualized dividend and a yield of 1.33%. UnitedHealth Group’s payout ratio is presently 36.12%.
Several brokerages recently issued reports on UNH. Cowen raised their target price on shares of UnitedHealth Group from $ 512.00 to $ 596.00 in a research note on Monday, April 18th. Barclays raised their price objective on shares of UnitedHealth Group from $ 495.00 to $ 565.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 30th. StockNews.com assumed coverage on shares of UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating for the company. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $ 613.00 to $ 612.00 and set an “overweight” rating for the company in a research report on Wednesday, May 25th. Finally, Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $ 564.00 to $ 595.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. Three investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $ 555.73.
In related news, Director Frederick William Mcnabb III acquired 89 shares of the company stock in a transaction dated Thursday, May 26th. The shares were purchased at an average price of $ 504.32 per share, for a total transaction of $ 44,884.48. Following the completion of the acquisition, the director now owns 11,259 shares of the company stock, valued at $ 5,678,138.88. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the company stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $ 493.25, for a total transaction of $ 1,233,125.00. Following the transaction, the director now owns 1,220,000 shares in the company, valued at approximately $ 601,765,000. The disclosure for this sale can be found here. 0.40% of the stock is owned by insiders.
UnitedHealth Group Company Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE: UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.